TMH Neuroscience Center -
[Cached Version]
Published on: 11/21/1999
Last Visited: 5/15/2005
Ricardo Ayala, MD, and his partner, Winston Ortiz, MD, specialize in treating epileptics and are engaged in research to increase the number of approved treatments for people suffering from seizures, especially children.
...
In discussing his research projects with a visitor, Dr. Ayala is at first reserved.He talks about the broader purpose for studies, but then his voice gains intensity as he describes the specific trials, clearly betraying his enthusiasm.
From about 1972 to 1993, there were no new treatments introduced for epileptics, he says.But in the past five years, there have been six new treatments introduced in the market."And I can tell you at least 10 more are in the works," he says.All this, thanks to doctors being willing to introduce trials to their clinical practice.
By conducting trials, Ayala says a physician is able to learn about new drugs coming on the market.More importantly, though, is the patient benefit."We're able to offer locally to all our patients all the treatment -- whether in investigative stages or approved," he says.
Ayala especially enjoys the physician-patient trust that is built through his research."You get to see them so often, and you get to more know about them -- they get to know more about you," he says.It builds a stronger bond of trust.
Serving as Principle Investigator for trials isn't a job that fits between the hours of nine to five, Ayala admits.Patients have the doctor's personal pager number and a physician is available to them 24 hours a day, 7 days a week."We're making a commitment to them and that takes time," Ayala says.